Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Jaffe

Showing results (871-880 of 1,423) with videos related to

Pageof 143
Sort By:
Clinical Biochemistry|August 17, 2015
Soluble ST2 and galectin-3 in pediatric patients without heart failureJeffrey W Meeusen, Jonathan N Johnson, Amber Gray, et al.
Clinical Chemistry|January 19, 2018
Clinical Laboratory Practice Recommendations for the Use of Cardiac Troponin in Acute Coronary Syndrome: Expert Opinion from the Academy of the American Association for Clinical Chemistry and the Task Force on Clinical Applications of Cardiac Bio-Markers of the International Federation of Clinical Chemistry and Laboratory MedicineAlan H B Wu, Robert H Christenson, Dina N Greene, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 21, 2005
Elevated donor troponin levels are associated with a lower frequency of allograft vasculopathyWayne L Miller, Brooks S Edwards, Walter K Kremers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2000
Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) in patients with hematologic malignanciesR J Kreitman, W H Wilson, J D White, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 4, 2000
The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997N L Harris, E S Jaffe, J Diebold, et al.
Leukemia & Lymphoma|January 11, 2019
Phase 1/2 study of alemtuzumab with dose-adjusted EPOCH in untreated aggressive T and NK cell lymphomasJoseph Roswarski, Mark Roschewski, Christopher Melani, et al.
Blood|September 15, 1993
Molecular analysis of the BCL-3 locus at chromosome 17q22 in B-cell neoplasmsT Yano, C A Sander, R E Andrade, et al.
Blood|November 14, 1997
The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative diseaseJ Teruya-Feldstein, E S Jaffe, P R Burd, et al.
Lancet (London, England)|December 11, 1993
Role of HTLV-I in development of non-Hodgkin lymphoma in Jamaica and Trinidad and Tobago. The HTLV Lymphoma Study GroupA Manns, F R Cleghorn, R T Falk, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 15, 2020
The mutational landscape of histiocytic sarcoma associated with lymphoid malignancyCaoimhe Egan, Justin Lack, Shannon Skarshaug, et al.
Pageof 143

Showing results (871-880 of 1,423) with videos related to

Sort By:
Pageof 143
Clinical Biochemistry|August 17, 2015
Soluble ST2 and galectin-3 in pediatric patients without heart failureJeffrey W Meeusen, Jonathan N Johnson, Amber Gray, et al.
Clinical Chemistry|January 19, 2018
Clinical Laboratory Practice Recommendations for the Use of Cardiac Troponin in Acute Coronary Syndrome: Expert Opinion from the Academy of the American Association for Clinical Chemistry and the Task Force on Clinical Applications of Cardiac Bio-Markers of the International Federation of Clinical Chemistry and Laboratory MedicineAlan H B Wu, Robert H Christenson, Dina N Greene, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 21, 2005
Elevated donor troponin levels are associated with a lower frequency of allograft vasculopathyWayne L Miller, Brooks S Edwards, Walter K Kremers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2000
Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) in patients with hematologic malignanciesR J Kreitman, W H Wilson, J D White, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 4, 2000
The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997N L Harris, E S Jaffe, J Diebold, et al.
Leukemia & Lymphoma|January 11, 2019
Phase 1/2 study of alemtuzumab with dose-adjusted EPOCH in untreated aggressive T and NK cell lymphomasJoseph Roswarski, Mark Roschewski, Christopher Melani, et al.
Blood|September 15, 1993
Molecular analysis of the BCL-3 locus at chromosome 17q22 in B-cell neoplasmsT Yano, C A Sander, R E Andrade, et al.
Blood|November 14, 1997
The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative diseaseJ Teruya-Feldstein, E S Jaffe, P R Burd, et al.
Lancet (London, England)|December 11, 1993
Role of HTLV-I in development of non-Hodgkin lymphoma in Jamaica and Trinidad and Tobago. The HTLV Lymphoma Study GroupA Manns, F R Cleghorn, R T Falk, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 15, 2020
The mutational landscape of histiocytic sarcoma associated with lymphoid malignancyCaoimhe Egan, Justin Lack, Shannon Skarshaug, et al.
Pageof 143